Anthrax Scare: Ranbaxy Stocks Up Ciprofloxacin
Ranbaxy Laboratories Ltd has increased its inventory of ciprofloxacin by 20-25 per cent following the anthrax scare in the country and abroad.
Explore Business Standard
Explore Business Standard
Ranbaxy Laboratories Ltd has increased its inventory of ciprofloxacin by 20-25 per cent following the anthrax scare in the country and abroad.
First Published: Oct 17 2001 | 12:00 AM IST